A method for modulating at least one pharmacokinetic property of a drug which degrades mRNA upon administration to a host by an siRNA mechanism is provided. In a further embodiment of this invention, a bifunctional compound comprising an siRNA and a recruiter moiety are provided. The recruiter moiety may be lipophilic and may enable the siRNA to cross cell membranes and then targets an endogenous, intracellular protein to allow better distribution of the therapeutic into the cell and therefore, higher efficacy.

 
Web www.patentalert.com

< ARTHROPLASTIC IMPLANT WITH SHIELD FOR BASILAR JOINT AND RELATED METHODS

> ARTHROPLASTIC IMPLANT WITH ANCHOR PEG FOR BASILAR JOINT AND RELATED METHODS

> Telomerase delivery by biodegradable Nanoparticle

~ 00524